Right now, AI is systematically favouring the kind of content your scientists produce every day. Peer-reviewed publications. Clinical data. Application notes with specific results. Expert author credentials that can be verified across platforms.
In health and science domains, AI models do not behave like consumer search. The platforms your brand manager is optimising for - Reddit threads, LinkedIn posts, YouTube videos - barely register in AI citation analysis for scientific queries. The platforms your scientists have been contributing to for years are the ones AI models prefer.
Most life science marketing teams are not connecting these dots.
The citation landscape is not what you think it is
An analysis of 36 million AI Overviews showed that in health and science domains; NIH content accounts for approximately 39% of citations, ScienceDirect approximately 11.5%, and established clinical organisations the balance. Social platforms barely register. This is dramatically different from consumer verticals, where YouTube and Reddit dominate citation pools.
For a life science tools company, this matters in a specific way. Your publications, your application notes, your white papers with real experimental data, your named scientists with verifiable credentials - these are AI citation magnets. But only if they are accessible, structured, and attributed correctly. If they are gated, anonymously authored, or scattered across inconsistent platforms, the advantage disappears.
Citation Compression is closing the window
Citation Compression - the structural narrowing of AI visibility to a small number of dominant brands per category - is already operating in life sciences. Research consistently shows that only five brands appear in approximately 80% of AI responses per B2B category. The dynamic is more binary than traditional search. A search engine had ten positions on the first page. An AI has a recommendation list. If you are not on it, you are not a consideration.
Strivenn survey finding (ELRIG Drug Discovery 2025, n=107 and SLAS 2026, n=43): 62% of exhibitors had never asked an AI to recommend companies in their product category. The same figure held across both events. Among those who had checked: 75% found themselves listed.
This is not a knowledge gap. These are commercially sophisticated organisations with marketing budgets and strategy teams. It is a prioritisation gap - and it reveals that most of the sector is still optimising for channels it understands while remaining invisible in the one that is growing fastest. That is the commercial cost of being in the Unconsidered Set: you do not see the deals you are not losing, because you were never in the conversation.
What's driving this urgency: the share of power AI users nearly tripled in just three months - from 6.6% to 18.6% between ELRIG and SLAS. Power users are the teams producing the content, building the communities, and referencing the suppliers that feed AI training data. The companies power users reference today become the most-cited brands tomorrow. The top is pulling away. The window is not closing slowly.
The gated content problem
Sixty percent of ChatGPT queries are answered from parametric knowledge - what the model learned during training. That means citations happening right now are partly shaped by the internet as it was when the model was trained. And the most credible scientific content your company has produced is often locked behind a gate.
If your best application note is behind a form, if your white paper requires a login, if your clinical validation data lives in a PDF that requires a sales conversation to access - AI models cannot see it, cannot cite it, and cannot recommend you based on it. You are invisible in the exact domain where your advantage is greatest.
This is a real tension. Gated content is a lead generation mechanism that has worked for years. But it trades top-of-funnel AI visibility for bottom-of-funnel data capture. As more initial vendor discovery moves into AI-mediated channels, the cost of that trade is rising.
The practical resolution is not to un-gate everything. It is to create ungated, structured summaries of your most credible content: a 300-word, schema-marked page that presents the key findings from your application note, with the methodology, the specific results, and the named scientist who ran the experiment - and a link to the full document behind the gate. The summary is what AI cites. The gate is still there for lead capture.
The ghostwriting problem
AI citation does not care about your agency.
It cares about named authors, institutional affiliation, citation patterns, and cross-domain reinforcement. If your content is ghostwritten and unattributed, AI has no verifiable expert to associate with the claim. The claim floats, unanchored.
A technical white paper attributed to a named senior research scientist with a verifiable LinkedIn profile, institutional affiliation, and a publication record in the same domain carries fundamentally different citation weight than the same paper published as "the team." Most life science marketing teams know this intuitively. AI citation mechanics make it structural, not optional.
You have structural authority. You are formatting it like a brochure.
Three moves for the next quarter
Three prioritised moves for a life science marketing leader building AI visibility without rebuilding the content programme:
- Audit your gated content. Map every application note, white paper, and technical comparison behind a form. For the top five by credibility and relevance, write ungated structured summaries of 200-400 words. Named authorship, specific results, schema-marked. This is one month of work and the highest-leverage single action available.
- Build entity profiles for your three most credible named scientists. Ensure their LinkedIn profiles, website bios, and any external database entries are consistent and link to their published work. Existing content immediately becomes more citable.
- Run the discoverability test quarterly. Open ChatGPT, Perplexity, Google AI Mode, and Claude. Ask the ten questions your ideal customer would ask when evaluating suppliers in your category. Log where you appear, where competitors appear, and what sources are cited. This baseline is more valuable than any agency audit report.
The advantage is real. Most of your competitors are not systematically thinking about this yet. The life science sector's natural orientation toward peer-reviewed evidence and named expertise is a structural AI citation advantage that no other industry shares.
Scientific credibility built trust with researchers for decades. In AI-mediated discovery, it is also the algorithm.
To learn more, visit the AI Discoverability Content Hub
